Decision to use the Vaccine for Cervical

The Ministry of Health decided to use the vaccine to protect girls against cancer of the cervix in the United Kingdom for change.

From September next year, the use of Gardasil jab, which also protects against genital warts - one of the most common diseases transmitted.

Some sexual health experts criticized the decision in 2008 when the Department of Health has opted for the cheaper of the two available vaccines - Cervarix.

Both vaccines protect against human papillomavirus (HPV) types 16 and 18, which cause over 70% of cancers of the cervix.

But Gardasil, the Ministry of Health has now chosen, it also protects against HPV types six to eleven most genital warts.

Figures of the Agency for Health Protection show that 75,000 people were diagnosed with genital warts in 2010.

Professor David Salisbury, director of the Government of the vaccination, said: "It is not unusual for the NHS to change vaccines or other drugs - can occur following a tender exercise or when new research comes to light. "

He denied that the wrong choice of the vaccine was three years ago, adding that the decisions were both then and now "scientifically and economically."

Dr. Steve Taylor, consultant in medicine at Birmingham Heartlands Hospital sexual health, said the news was "fantastic."

He added: "In Australia, the burden of genital warts has fallen dramatically since the introduction of the quadrivalent vaccine (Gardasil).

"We felt the last time the decision was based on the cost of the vaccine, but the reduction in the cost of sexual health clinics is not taken into account."